Clinical Trial Update: Hematopoietic Stem Cell Support Versus Insulin in T1D [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating hematopoietic stem cell support as an alternative to insulin in Type 1 diabetes, which has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Northwestern University | Conditions: Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: WITHDRAWN